INSIGHTS ON DRUG DEVELOPMENT

• Improving The Efficiency And Quality Of Advanced Imaging And Analysis

  Human-relevant models are transforming drug screening. Find out how overcoming 3D cell culture challenges with integrated innovations accelerates discovery and brings effective treatments to patients faster.

• Development Of A High Sensitivity SPE-LC-MS/MS Assay

  Achieve ultra-sensitive glucagon quantification with ionKey/MS, μElution SPE, and advanced MS fragmentation to deliver low LOD, reduced sample loss, and enhanced confidence in results.

• If Collaboration Fuels Biopharma Innovation, Why Can't We Connect More?

  Breakthroughs thrive when biopharma teams work across silos, yet collaboration remains surprisingly difficult. Explore the barriers and why they persist. What will it take to move beyond them?

• Three Keys To E&L Success: Study Design, Partner Selection, And Timing

  Successful E&L planning starts before testing begins. Aligning study design, partner expertise, and timing helps teams focus on the right risks, avoid surprises, and support stronger development.

• Simplify Process Scale-Up With An Innovative Single-Use Bioreactor

  10/15/2025

  Consistent cell growth and protein yields from 5 L to 5,000 L show how a unified bioreactor design can simplify scale-up, reduce risk, and accelerate upstream process development in bioproduction.

• New Approach Methodologies: The Future Of Toxicology And Safety Testing

  6/25/2026

  NAMs are transforming toxicology with human-relevant, non-animal approaches. Learn what defines a NAM, how these methods work together, and why adoption is rapidly accelerating.

• Generate CHO-K1 GFP-Expressing Cells For Cell Line Development Workflow

  11/7/2025

  Discover a high-efficiency workflow for generating GFP-expressing CHO-K1 clones using automated single-cell dispensing to achieve 93% isolation success and stable expression in under five weeks.

• Solving Bioavailability Challenges In bRo5 Drugs

  3/20/2026

  Leverage mechanistic, material-sparing formulation strategies to enhance bioavailability and accelerate development of challenging bRo5 small molecules, even with limited resources.

• Mammalian Expression

  5/28/2026

  See how a biotechnology company advanced an engineered protein therapeutic while navigating development, regulatory, and scalability challenges.